CDC makes recommendations on the use of HPV vaccine in males

The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of males aged 11 or 12 years with HPV4 administered as a 3-dose series (recommendation category: A, evidence type: 2§). The vaccination series can be started beginning at age 9 years. Vaccination with HPV4 is recommended for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series. Males aged 22 through 26 years may be vaccinated.

HPV has been identified as the cause of certain cervical cancers in women.  It also the cause of some throat and mouth cancers along with genital warts in both men and women.  The virus is sexually transmitted.

The side effects of the vaccine is nominal, no different than most other vaccines.  And soon will hear from the anti-vaccination crowd telling us how HPV is not that bad and there are many risks from the vaccine.

Source:  Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011.

The Original Skeptical Raptor
Chief Executive Officer at SkepticalRaptor
Lifetime lover of science, especially biomedical research. Spent years in academics, business development, research, and traveling the world shilling for Big Pharma. I love sports, mostly college basketball and football, hockey, and baseball. I enjoy great food and intelligent conversation. And a delicious morning coffee!